Psychosocial Risk Factors and Perceived Well‐Being in Survivors of Gastrointestinal Cancer
Psycho-Oncology · 2025
DOI: 10.1002/pon.70302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psycho-Oncology, 2025. Verfasst von Samuel D Butensky und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Cancer Survivors, Gastrointestinal Neoplasms, Mental Health, Survivors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: NCI NIH HHS, NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
There are 18 million cancer survivors in the United States; 10% have gastrointestinal (GI) cancer. Psychosocial risk factors (PSRF) and perceived health (PH) are important to their well‐being.
Aims
This study examines PSRF among survivors of GI cancer and evaluates their association with PH.
Methods
A cross‐sectional analysis of the All of Us Research Program included survivors of GI cancer who completed Social Determinants of Health and Overall Health surveys. PSRF were assessed using validated scales. Regression models evaluated associations between PSRF and PH.
Results
13,813 patients with GI cancer were included. Female patients were more likely to perceive good physical health (OR 1.52 [95% CI: 1.30–1.79]) than male patients. Black patients reported higher discrimination (β 0.25 [95% CI: 0.20–0.31]) compared to white patients. Increased loneliness and stress decreased the odds of reporting good mental health by 53% (OR 0.47 [95% CI: 0.39–0.56]) and 39% (OR 0.61 [95% CI: 0.50–0.74]), respectively. Increased spirituality was associated with improved perceived mental health (OR 1.12 [95% CI: 1.06–1.17]). Healthcare discrimination (OR 0.87 [95% CI: 0.79–0.97]) and loneliness (OR 0.84 [95% CI: 0.73–0.97]) were negatively associated with perceived physical health. Social support (OR 1.16 [95% CI: 1.06–1.26]) and spirituality (OR 1.08 [95% CI: 1.02–1.14]) were positively associated with quality of life.
Conclusion
Protective PSRF such as social support and spirituality are correlated with better perceived health in survivors of GI cancer. Tailoring supportive services based on patient‐reported experience may help improve quality of life in cancer survivorship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA.
- Department of Biomedical Informatics and Data Science, Yale University School of Medicine, New Haven, Connecticut, USA.
- Department of Medical Oncology and Hematology, Yale University School of Medicine, New Haven, Connecticut, USA.
- Department of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut, USA.
- Division of Colon and Rectal Surgery, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA.
- Division of Surgical Oncology, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA.
ORCID-Profile: Samuel D Butensky, Kurt S Schultz, Elizabeth L Godfrey, Caroline H Johnson, Ira L Leeds
Förderung
- NCI NIH HHS
- NIH HHS
- NCATS NIH HHS
Zitieren
APA
Butensky, S. D., Schultz, K. S., Godfrey, E. L., Kim, J., Sanft, T., Johnson, C. H., Leeds, I. L., & Khan, S. A. (2025). Psychosocial Risk Factors and Perceived Well‐Being in Survivors of Gastrointestinal Cancer. Psycho-Oncology. https://doi.org/10.1002/pon.70302
Vancouver
Butensky SD, Schultz KS, Godfrey EL, Kim J, Sanft T, Johnson CH, et al. Psychosocial Risk Factors and Perceived Well‐Being in Survivors of Gastrointestinal Cancer. Psycho-Oncology. 2025. doi:10.1002/pon.70302
BibTeX
@article{Butensky2025,
author = {Butensky, Samuel D and Schultz, Kurt S and Godfrey, Elizabeth L and Kim, Jihoon and Sanft, Tara and Johnson, Caroline H and Leeds, Ira L and Khan, Sajid A},
title = {Psychosocial Risk Factors and Perceived Well‐Being in Survivors of Gastrointestinal Cancer},
journal = {Psycho-Oncology},
year = {2025},
doi = {10.1002/pon.70302}
}
EUVIMED